Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Povidone Iodine (PVI) to Prevent Staphylococcus Aureus Surgical Site Infections After Operative Procedures to Fix High-Energy Lower Extremity Fractures (POTENT Study)

NCT05763602 is registered in ClinicalTrials.gov with Loreen Herwaldt as lead sponsor.

NCT NCT05763602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05763602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Povidone Iodine (PVI) to Prevent Staphylococcus Aureus Surgical Site Infections After Operative Procedures to Fix High-Energy Lower Extremity Fractures (POTENT Study)
Lead sponsor
Loreen Herwaldt
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 15, 2022
Completion date
May 31, 2026
Enrollment
2,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

surgical site infection